knowledge -WSS

knowledge

author：entertainment 2025-10-01 22:16:26 - browse：4838

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Regeneron agrees to White House price limits on anti

WSS

Superbugs, antibiotic resistance get scrutiny in congress

Pig kidney works a record two months in donated body

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

New weight loss drugs vying to be the next Wegovy or Mounjaro

Britney Spears to release memoir, 'The Woman In Me,' later this year

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Wikipedia

knowledge

focus

The high cost of giving birth even with insurance

Cuban government calls US nuclear submarine stop a 'provocative escalation'

United colonoscopy coverage change 'may cost lives,' doctors say

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

In Memoriam: Notable people who died in 2023

Grail's uphill battle for Medicare to cover its cancer screening test

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Will the IRA bring competition to the biologics market?

The high cost of giving birth even with insurance

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

focus

Pig kidney works a record two months in donated body

Pig kidney works a record two months in donated body

Inflation cooled significantly in June, bringing price hikes close to normal levels

New weight loss drugs vying to be the next Wegovy or Mounjaro

Britney Spears to release memoir, 'The Woman In Me,' later this year

Generate Biomedicines machine learning biotech raises $273M

leisure time

focus

knowledge

focus